Topics
News
CME/CE
Editorial Advisory Board
Partners
Subscribe
- General Dermatology
- Eczema
- Chronic Hand Eczema
- Alopecia
- Aesthetics
- Vitiligo
- COVID-19
- Actinic Keratosis
- Precision Medicine and Biologics
- Rare Disease
- Wound Care
- Rosacea
- Psoriasis
- Psoriatic Arthritis
- Atopic Dermatitis
- Melasma
- NP and PA
- Skin Cancer
- Hidradenitis Suppurativa
- Drug Watch
- Pigmentary Disorders
- Acne
- Pediatric Dermatology
- Practice Management
- Prurigo Nodularis
Article
A Dose of Precision
Oracea® 40-mg Capsules are the only FDA-approved oral formulation to treat the inflammatory lesions of rosacea. Oracea® 40-mg Capsules are precisely formulated with a uniquely designed release system, providing an immediate and delayed, non-antibiotic dose for anti-inflammatory control throughout the day.
Oracea® 40-mg Capsules are the only FDA-approved oral formulation to treat the inflammatory lesions of rosacea.
Oracea® 40-mg Capsules are precisely formulated with a uniquely designed release system, providing an immediate and delayed, non-antibiotic dose for anti-inflammatory control throughout the day.
Related Videos
Related Content
